Tag: BioVoice News
“Digital technologies are creating a future where care is faster, safer,...
Dr Nikhil Mathur, Group Chief of Medical Services, CARE Group of Hospitals shares insights on the India’s healthcare system, his hospital group’s latest initiatives, tech adoption and more
Face to Face with BioVoice News: Dr Sajeev Nair, Founder &...
Dr. Sajeev Nair, Founder & Chairman of Vieroots speaks about the company’s science-driven, personalized approach to preventive healthcare through genomics, epigenetics, and AI.
India Unlimited 3.0: Experts say India has the Talent, Tech, and...
With end-to-end capabilities, India is rapidly scaling up its global presence in discovery, development, and manufacturing
Bridging Science and Business: The Missing Link in Bioscience Innovation
The full potential of bioscience sector can only be realized through a collaborative ecosystem where academia and industry function as complementary forces
FACE TO FACE: Dr Taslimarif Saiyed, Director and CEO, Centre for Cellular...
Taslimarif Saiyed, Director and CEO, Centre for Cellular and Molecular Platforms (C-CAMP) talks about the relevance of Startup Mahakumbh event, key factors driving startup ecosystem, latest trends, challenges and much more.
India Biotech Outlook 2025: The India Advantage at BIO Boston 2025
BioVoice News and the International Contract Pharma Association (ICPA) have collaborated to present an exclusive publication that will highlight India’s leadership in biotech and provide a powerful platform for companies to maximize their presence
Intuitive appoints Rohitt Mahajan as new Vice President & General Manager...
Mahajan brings more than 17 years of diverse experience in sales, marketing, strategy, and operations in the healthcare, consumer durables, and IT sectors
HMPV Outbreak: Union Health Secretary reviews situation, asks states to remain...
States advised to strengthen awareness among masses regarding preventive measures
City Imaging & Clinical Labs introduces advanced flow cytometry testing
This cutting-edge technology enables rapid, precise analysis for conditions like cancer and immune disorders
‘Gene silencing’ therapies market set to boom, says leading biotech
SynaptixBio, the only company licensed to commercialise a treatment for a rare, deadly disease, says the technology it uses will become widely adopted for the treatment of many diseases